Added to YB: 2024-01-02
Pitch date: 2024-01-02
MXCT [bullish]
MaxCyte, Inc.
-59.74%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
Market Cap
$76.8M
Pitch Price
$3.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.25
P/E
-1.67
EV/Sales
-0.31
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Fundamentals and technicals align in $MXCT
$MXCT: Bullish on fundamentals & technicals aligning. Exposure to gene therapy via picks & shovels. Volume up, FDA approval, could be like buying $AAPL post-iPhone launch.
Read full article (1 min)